Leading research progress and prospect of gynecological oncology in 2020

朱　俊; 吴小华

doi:10.19401/j.cnki.1007-3639.2021.04.002

您当前的位置：

首页 >

文章列表页 >

Leading research progress and prospect of gynecological oncology in 2020

更新时间：2026-01-27

- Leading research progress and prospect of gynecological oncology in 2020
- China Oncology Vol. 31, Issue 4, Pages: 250-256(2021)
- 作者机构：
  
  复旦大学附属肿瘤医院妇瘤科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2021.04.002
  CLC： R737.3
- Published Online：28 April 2021，
  
  Published：28 April 2021
- 稿件说明：
移动端阅览
朱　俊, 吴小华. 2020年度妇科恶性肿瘤最新研究进展及展望[J]. 中国癌症杂志, 2021, 31(4): 250-256.

朱　俊, 吴小华. Leading research progress and prospect of gynecological oncology in 2020[J]. China Oncology, 2021, 31(4): 250-256.
朱　俊, 吴小华. 2020年度妇科恶性肿瘤最新研究进展及展望[J]. 中国癌症杂志, 2021, 31(4): 250-256. DOI： 10.19401/j.cnki.1007-3639.2021.04.002.

朱　俊, 吴小华. Leading research progress and prospect of gynecological oncology in 2020[J]. China Oncology, 2021, 31(4): 250-256. DOI： 10.19401/j.cnki.1007-3639.2021.04.002.

摘要

妇科肿瘤领域在过去1年取得了诸多重磅性研究成果，三大常见妇科恶性肿瘤，包括宫颈癌、子宫体癌和卵巢癌，在手术治疗、辅助治疗及靶向治疗方面均有突破性进展。靶向治疗的应用使卵巢癌患者的生存状况得到了极大程度的改善，对于特定人群的卵巢癌患者，靶向治疗带来了显著的生存获益。在手术治疗方面，宫颈癌根治性手术在传统开腹手术与腹腔镜手术之间的安全性比较有了更多研究数据；子宫内膜癌早期手术治疗模式也在不断更新。

Abstract

There have been many leading research achievements in the past year in the field of gynecologic oncology. Breakthroughs in surgical treatment

adjuvant therapy and targeted therapy have been made in the common gynecological malignancies

including cervical cancer

uterine cancer and ovarian cancer. Targeted therapy has greatly improved the prognosis of patients with ovarian cancer. For a specific kind of ovarian cancer patients

targeted therapy has resulted in significant survival improvement. In terms of surgical treatment

more research has been conducted on the safety of radical laparoscopic surgery for cervical cancer compared with laparotomy surgery. Surgical modality for endometrial cancer is constantly updated and explored as well.

关键词

Keywords

references

Views

5765

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

The latest progress and prospect of gynecological tumor treatment at 2023 ESMO

The progress of treatment for brain metastases of triple-negative breast cancer

Clinical research progress of intrathecal therapy in the treatment of leptomeningeal metastasis

Progress in treatment of gynecological cancer in 2023

Related Author

Sumei FAN

Congling XIN

Laifang ZHU

Chang LIU

Rui XU

Zhengrong ZHOU

Xi CHENG

Lingfang XIA

Related Institution

Department of Surgical Oncology, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Pharmacy, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Diagnostic Radiology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

Department of Diagnostic Radiology, Minhang Branch, Fudan University Shanghai Cancer Center

Department of Gynecological Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University

AI问答

⁰